Zelosartan Tablet 50 mg (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
MFDS item code 201801267 · Approved 2018.03.23
This product's status changed to Approval withdrawn on 2025.07.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication helps effectively control the blood pressure of patients with hypertension. It is especially useful in preventing and treating kidney disease in patients with hypertension and type 2 diabetes. It contributes to blood pressure management and protects kidney function, thereby improving the overall health of patients. Therefore, it is widely used for the treatment of hypertension and diabetes-related kidney disease.
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension — Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium administered orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be administered orally in 2 divided doses daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this drug alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. Elderly patients over 75 years of age: The recommended initial dose is 25 mg of this drug once daily. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: The recommended initial dose is 25 mg of this drug once daily. For patients who may have reduced intravascular volume (e.g., patients receiving diuretics), the recommended initial dose is 25 mg of this drug once daily (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more and less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. It should not be used in patients with severely impaired liver function, hereditary angioedema, or primary hyperaldosteronism, and caution is needed for patients with lactose intolerance. Elderly patients, patients with compromised kidney function, and those with hyperkalemia should take this medication carefully while frequently checking blood tests and their condition. Dizziness or symptoms of low blood pressure may occur while taking this medication, so caution should be exercised when driving or operating machinery. This medication may increase potassium levels to dangerous levels if taken with other antihypertensive drugs, potassium-sparing diuretics, or potassium supplements, so it is essential to consult with a doctor. Additionally, taking this medication with nonsteroidal anti-inflammatory drugs (NSAIDs) may hinder blood pressure control or worsen kidney function, requiring careful attention. During the use of this medication, side effects such as liver dysfunction, kidney impairment, blood abnormalities, and skin rashes may appear, so if any unusual symptoms occur, it is necessary to inform medical personnel immediately. Women who are pregnant or breastfeeding should avoid taking this medication, and if it is absolutely necessary to take it, they must consult with a doctor and discontinue breastfeeding. In case of overdose, hypotension and bradycardia may occur, necessitating immediate medical treatment, and this medication is not removed by hemodialysis. This medication should be stored out of the reach of children, and it is safe not to transfer it to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air and moisture, ideally at temperatures between 1 degree and 30 degrees Celsius. Therefore, avoid areas that are too hot or too cold, and keep it in a cool place away from direct sunlight.
White oval film-coated tablets
30, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium 50mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.